Alnylam Pharmaceuticals Stock In Shambles: Down 14% With 5-Day Losing Streak

Category: Markets

Published: 2026-07-16T12:42:42.000Z

Alnylam Pharmaceuticals (NASDAQ: ALNY) stock has experienced a significant downturn, dropping 14% and marking a five-day losing streak. This indicates a challenging period for the company's market performance.

Read the original source

News summary curated and translated by CausifyMarket. Always consult original sources before making any financial decision.